VP, Corporate Communications and Investor Relations at Dyne Therapeutics
Amy brings nearly 20 years of experience in corporate communications in the life science industry to her role at Dyne, including managing investor relations, building employee communications programs, expanding corporate philanthropic initiatives, and executing product launch communications. Prior to joining Dyne, Amy was Vice President, Communications and Investor Relations at Kaleido Biosciences, during which time she helped lead the company’s Initial Public Offering, implemented digital and social media activities as well as oversaw internal and executive communications. Amy previously managed corporate communications at ImmunoGen, led philanthropy and employee communications at Cubist Pharmaceuticals, and held various roles at Biogen, including managing product communications for its multiple sclerosis franchise and media relations, as well as overseeing the company’s Foundation. Amy received her A.B. in English and American Literature from Bowdoin College.